Sign In
Buy BLU
$14.74
+0 (+0%)
At Close: Sep 27, 2023
BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough
09:00pm, Monday, 06'th Apr 2020
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the "Company" or "BELLUS Health") , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hy
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
11:36am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2)BELLUS Health Inc (NASDAQ: BLU)Down In The Dumps (Biote
BELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations
06:07pm, Wednesday, 25'th Mar 2020
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the "Company" or "BELLUS Health") is pleased to announce that it has closed the transaction announced on March 23, 2020 (the "Transaction") in accordance wi
Selloff creating bargains in healthcare - Baird
05:54pm, Wednesday, 25'th Mar 2020
Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVI
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
11:29am, Wednesday, 25'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord
BELLUS Health Announces Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations
11:31am, Monday, 23'rd Mar 2020
BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the "Company" or "BELLUS Health"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hyp
BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
11:00am, Thursday, 19'th Mar 2020
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (the "Company" or "BELLUS Health"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hyper
Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL) and BELLUS Health (BLU)
01:19am, Wednesday, 18'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Madrigal Pharmaceuticals (MDGL) and BELLUS Health (BLU)
Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (NASDAQ: MDGL) and BELLUS Health (NASDAQ: BLU)
01:19am, Wednesday, 18'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Madrigal Pharmaceuticals (
MDGL
–
Research Report
) and BELLUS Health (
BLU
–
Research Report
) wit
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
Have Insiders Been Buying BELLUS Health Inc. (TSE:BLU) Shares This Year?
10:18am, Friday, 21'st Feb 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
Analysts Estimate Bellus Health (BLU) to Report a Decline in Earnings: What to Look Out for
05:31pm, Thursday, 13'th Feb 2020
Bellus (BLU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Worry About BELLUS Health Inc.'s (TSE:BLU) CEO Salary Level?
10:21am, Thursday, 16'th Jan 2020
In 2010 Roberto Bellini was appointed CEO of BELLUS Health Inc. (TSE:BLU). This report will, first, examine the CEO...
Herc Holdings Inc. (HRI) vs. Top 20 Hedge Fund Stocks in 2019
09:31pm, Thursday, 09'th Jan 2020
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick thei
Hedge Funds Welcomed BELLUS Health Inc. (BLU) With Open Arms
04:16pm, Friday, 13'th Dec 2019
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing more than 750
